Natalie Halladin

Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial

Liana K. Billings, Ankur Doshi, D. Gouet et al. · Diabetes Care · 2018 · 188 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Oxidative and inflammatory biomarkers of ischemia and reperfusion injuries.

Natalie Halladin · PubMed · 2015 · 100 citations

Veterinary Medicine, Pathobiology, Surgery +15

Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial

Vanita R. Aroda, Guillermo González-Gálvez, Randi Grøn et al. · The Lancet Diabetes & Endocrinology · 2019 · 67 citations

Medicine, Endocrinology, Pharmacology +13

Safety and efficacy of <scp>IDegLira</scp> titrated once weekly versus twice weekly in patients with type 2 diabetes uncontrolled on oral antidiabetic drugs: <scp>DUAL VI</scp> randomized clinical trial

Stewart B. Harris, Győző Kocsis, Rudolf Prager et al. · Diabetes Obesity and Metabolism · 2017 · 66 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Superior efficacy of insulin degludec/liraglutide versus insulin glargine U100 as add‐on to sodium‐glucose co‐transporter‐2 inhibitor therapy: A randomized clinical trial in people with uncontrolled type 2 diabetes

Athena Philis‐Tsimikas, Liana K. Billings, Robert S. Busch et al. · Diabetes Obesity and Metabolism · 2019 · 66 citations · Full text

Medicine, Endocrinology, Pharmacology +16